dr lal pathlabs: q1, margins, expansion plans & capex | dr. om manchanda explains | business news
Published 1 year ago • 316 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
8:33
dr lal path labs' om manchanda speaks on q4 performance & fy24 margin outlook | cnbc-tv18
-
9:40
'q1 capex investment stood at rs 4000 crore': tata power ceo & md on the talking point
-
9:40
hindustan zinc ceo on q1 results, expansion plans, capex & more
-
14:03
dr lal pathlabs ceo explains business model
-
3:16
dr. om manchanda, ceo of dr lal pathlabs speaks on q1 revenue
-
14:03
dr lal pathlabs ceo explains business model
-
5:12
dr lal pathlabs on their ipo - dec 8
-
4:52
dilip piramal of v.i.p industries speaks on the robust q3 topline growth
-
13:37
dr om manchanda, md, dr lal pathlabs on strong q4 results & growth plans for fy25
-
9:16
price increase is one of the reasons for the margin expansion: dr lal pathlabs | cnbc tv18
-
1:08
dr lal pathlabs' om manchanda on margins | bq prime
-
7:03
gsfc q1: strong profits & margins recorded, what's the demand outlook? | sk bajpai | business news
-
5:48
margins on track to return to pre-covid levels | om prakash manchanda, dr lal pathlabs
-
9:12
aspiration is to grow in double digit with margin at 26% in fy25: dr lal pathlabs | cnbc tv18
-
16:07
dr lal path labs' om manchanda exclusive on the changing landscape of diagnostics | the medicine box
-
8:50
dr om manchanda on dr lal pathlabs' weak q3 earnings & outlook | bazaar corporate radar | cnbc-tv18
-
9:57
q4 review | how dr. lal pathlabs plans to improve financials
-
11:29
q1 review: dr lal pathlabs' ceo on earnings & outlook for upcoming quarters | bq prime
-
9:12
dr lal pathlabs: improvement in revenue mix, company's plan to achieve double digit growth in fy25?
-
7:40
dr lal path labs on co’s growth rate | et now
-
3:57
expansion into new territories to boost growth: dr lal pathlabs
-
20:01
veterinarian to ceo via kilimanjaro | om manchanda | md, dr. lal pathlabs | episode 15 | qunba